BLC
TDOC icon

Brown, Lisle/Cummings’s Teladoc Health TDOC Stock Holding History

Brown, Lisle/Cummings’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-450
Closed -$3.48K – 766
2025
Q3 		$3.48K Hold
450
– – ﹤0.01% 602
2025
Q2 		$3.92K Hold
450
– – ﹤0.01% 589
2025
Q1 		$3.58K Hold
450
– – ﹤0.01% 593
2024
Q4 		$4.09K Sell
450
-50
-10% -$483 ﹤0.01% 553
2024
Q3 		$4.59K Sell
500
-50
-9% -$414 ﹤0.01% 520
2024
Q2 		$5.38K Buy
550
+100
+22% +$1.22K ﹤0.01% 504
2024
Q1 		$6.79K Hold
450
– – ﹤0.01% 470
2023
Q4 		$9.7K Hold
450
– – ﹤0.01% 446
2023
Q3 		$8.37K Buy
+450
New +$10.5K ﹤0.01% 428

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Brown, Lisle/Cummings's TDOC Position: Q4 2025 in Review

Brown, Lisle/Cummings sold out of Teladoc Health (TDOC) in Q4 2025, closing a stake of 450 shares — an estimated $3.48K sold.

Brown, Lisle/Cummings first reported a position in TDOC in Q3 2023 and held it in 9 quarters. The position peaked at $9.7K in Q4 2023. 344 funds tracked by Wall St. Rank hold TDOC as of Q4 2025.

  • Brown, Lisle/Cummings reported no remaining Teladoc Health position as of Q4 2025 after selling out during the quarter.
  • Brown, Lisle/Cummings sold 450 Teladoc Health shares in Q4 2025, an estimated $3.48K.
  • Brown, Lisle/Cummings first reported a position in Teladoc Health in Q3 2023 and held it in 9 quarters.
  • Brown, Lisle/Cummings's Teladoc Health position peaked at $9.7K in Q4 2023.
  • 344 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2025.

Based on Brown, Lisle/Cummings's 13F filing for Q4 2025, filed 23 Jan 2026.